Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial

Radmila Lyubarova,John J. Albers,Santica M. Marcovina,Yao Yao,Ruth McBride,Alexandru Topliceanu,Todd Anderson,Jerome L. Fleg,Patrice Desvigne-Nickens,Moti L. Kashyap,Mark E. McGovern,William E. Boden

Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial

2019

Radmila Lyubarova
John J. Albers
Santica M. Marcovina
Yao Yao
Ruth McBride
Alexandru Topliceanu
Todd Anderson
Jerome L. Fleg
Patrice Desvigne-Nickens
Moti L. Kashyap
Mark E. McGovern
William E. Boden

Background:Lipoprotein-associated phospholipase A2 (LpPLA2) is an inflammatory marker that has been associated with the presence of vulnerable plaque and increased risk of cardiovascular (CV) event...

Keywords:

Diabetes mellitus
Internal medicine
Niacin
Disease
Statin
Post-hoc analysis
Cholesterol
Cardiology
Quartile
Medicine
High-density lipoprotein
Vulnerable plaque

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations